PROTAC MLKL Degrader-1

CAT:
804-HY-156591-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
PROTAC MLKL Degrader-1 - image 1

PROTAC MLKL Degrader-1

  • CAS Number:

    3032600-90-8
  • UNSPSC Description:

    PROTAC MLKL Degrader-1 (Compound 36) is a PROTAC degrader of MLKL, with a Dmax >90%. PROTAC MLKL Degrader-1 contains modified CRBN ligands, linker and Lenalidomide (HY-A0003)-linker fragments. PROTAC MLKL Degrader-1 abrogates cell death in a TSZ model of necroptosis.
  • Target Antigen:

    Mixed Lineage Kinase; PROTACs
  • Type:

    Reference compound
  • Related Pathways:

    MAPK/ERK Pathway;PROTAC
  • Applications:

    Cancer-Kinase/protease
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/protac-mlkl-degrader-1.html
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C(C1=C(NN=C1C2=CC=C(C=C2)NS(C(F)F)(=O)=O)NC3=CC=CC(OCCCCCCCC(N4CCC5(CCN(CC5)C(C6=CC=C(C(N7CCC(NC7=O)=O)=C6)OC)=O)CC4)=O)=C3)N
  • Molecular Weight:

    948.05
  • References & Citations:

    [1]Rathje OH, Perryman L, Payne RJ, Hamprecht DW. PROTACs Targeting MLKL Protect Cells from Necroptosis. J Med Chem. 2023 Aug 3.
  • Shipping Conditions:

    Room Temperature
  • Clinical Information:

    No Development Reported